These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12557866)

  • 41. Pharmacogenetics of beta1-adrenergic receptors in heart failure and hypertension.
    Mialet-Perez J; Liggett SB
    Arch Mal Coeur Vaiss; 2006 Jun; 99(6):616-20. PubMed ID: 16878723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study.
    Covolo L; Gelatti U; Metra M; Nodari S; Piccichè A; Pezzali N; Zani C; Alberti A; Donato F; Nardi G; Dei Cas L
    Eur Heart J; 2004 Sep; 25(17):1534-41. PubMed ID: 15342173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacogenetics and healthcare outcomes in patients with chronic heart failure.
    Kim KM; Murray MD; Tu W; Robarge J; Ding Y; Brater DC; Flockhart DA
    Eur J Clin Pharmacol; 2012 Nov; 68(11):1483-91. PubMed ID: 22543981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha 2-adrenergic receptor gene polymorphism and hypertension in blacks.
    Lockette W; Ghosh S; Farrow S; MacKenzie S; Baker S; Miles P; Schork A; Cadaret L
    Am J Hypertens; 1995 Apr; 8(4 Pt 1):390-4. PubMed ID: 7619352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic variation within the beta1-adrenergic receptor gene results in haplotype-specific expression phenotypes.
    Small KM; Mialet-Perez J; Liggett SB
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):106-10. PubMed ID: 18209576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy.
    Terra SG; Hamilton KK; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hill JA; Aranda JM; Yarandi HN; Johnson JA
    Pharmacogenet Genomics; 2005 Apr; 15(4):227-34. PubMed ID: 15864115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure.
    de Groote P; Helbecque N; Lamblin N; Hermant X; Mc Fadden E; Foucher-Hossein C; Amouyel P; Dallongeville J; Bauters C
    Pharmacogenet Genomics; 2005 Mar; 15(3):137-42. PubMed ID: 15861037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure.
    Wagoner LE; Craft LL; Zengel P; McGuire N; Rathz DA; Dorn GW; Liggett SB
    Am Heart J; 2002 Nov; 144(5):840-6. PubMed ID: 12422153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adrenergic Polymorphisms and Survival in African Americans With Heart Failure: Results From A-HeFT.
    Johnson AE; Hanley-Yanez K; Yancy CW; Taylor AL; Feldman AM; McNamara DM
    J Card Fail; 2019 Jul; 25(7):553-560. PubMed ID: 30978507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Interactions between beta1 and beta2 adrenergic receptor polymorphisms as risk factors for chronic heart failure].
    Moraga F; Troncoso R; Mellado R; Díaz-Araya G; Vukasovic JL; Greig D; Perez O; García L; Roldán J; Ocaranza MP; Jali J; Chiong M; Castro P
    Rev Med Chil; 2008 Nov; 136(11):1371-80. PubMed ID: 19301767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
    Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
    Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of beta-adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure.
    de Groote P; Lamblin N; Helbecque N; Mouquet F; Mc Fadden E; Hermant X; Amouyel P; Dallongeville J; Bauters C
    Eur J Heart Fail; 2005 Oct; 7(6):966-73. PubMed ID: 16227135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline.
    Snapir A; Koskenvuo J; Toikka J; Orho-Melander M; Hinkka S; Saraste M; Hartiala J; Scheinin M
    Clin Sci (Lond); 2003 May; 104(5):509-20. PubMed ID: 12519093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic drug evaluation of bucindolol for the treatment of atrial fibrillation in heart failure patients.
    Rosa GM; Meliota G; Brunelli C; Ferrero S
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):473-481. PubMed ID: 28162002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results.
    Pezzali N; Curnis A; Specchia C; Carubelli V; Covolo L; Donato F; Auricchio A; Regoli F; Metra M
    Europace; 2013 Oct; 15(10):1475-81. PubMed ID: 23729404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The human G147D-protein phosphatase 1 inhibitor-1 polymorphism is not associated with altered clinical characteristics in heart failure.
    Chen G; Zhou X; Pathak A; Dorn GW; Kranias EG
    Cardiology; 2009; 112(3):224-31. PubMed ID: 18698139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response to catecholamine stimulation of polymorphisms of the beta-1 and beta-2 adrenergic receptors.
    McLean RC; Baird SW; Becker LC; Townsend SN; Gerstenblith G; Kass DA; Tomaselli GF; Schulman SP
    Am J Cardiol; 2012 Oct; 110(7):1001-7. PubMed ID: 22742717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study.
    White HL; de Boer RA; Maqbool A; Greenwood D; van Veldhuisen DJ; Cuthbert R; Ball SG; Hall AS; Balmforth AJ;
    Eur J Heart Fail; 2003 Aug; 5(4):463-8. PubMed ID: 12921807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between β1 adrenergic receptor gene Arg389Gly polymorphism and risk of heart failure: a meta-analysis.
    Ma ST; Zhao W; Liu B; Jia RY; Zhao CJ; Cui LQ
    Genet Mol Res; 2015 Jun; 14(2):5922-9. PubMed ID: 26125791
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frequency of genetic polymorphism for adrenergic receptor beta and cytochrome p450 2D6 enzyme, and effects on tolerability of beta-blocker therapy in heart failure with reduced ejection fraction patients: The Beta GenTURK study.
    Zoghi M; Kaya H; Çavuşoğlu Y; Aksakal E; Demir Ş; Yücel C; Mutlu H; Ergene O; Yılmaz MB;
    Turk Kardiyol Dern Ars; 2016 Sep; 44(6):457-65. PubMed ID: 27665326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.